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Abstract: The development of chronic, low-grade systemic inflammation in the elderly 
(inflammaging) has been associated with increased incidence of chronic diseases, geriatric 
syndromes, and functional impairments. The aim of this study was to examine differences in 
habitual physical activity (PA), dietary intake patterns, and musculoskeletal performance among 
community-dwelling elderly men with low and elevated systemic inflammation. Nonsarcopenic 
older men free of chronic diseases were grouped as ‘low’ (LSI: N = 17; 68.2 ± 2.6 years; hs-CRP: <1 
mg/L) or ‘elevated’ (ESI: N = 17; 68.7 ± 3.0 years; hs-CRP: >1 mg/L) systemic inflammation 
according to their serum levels of high-sensitivity CRP (hs-CRP). All participants were assessed for 
body composition via Dual Emission X-ray Absorptiometry (DEXA), physical performance using 
the Short Physical Performance Battery (SPPB) and handgrip strength, daily PA using 
accelerometry, and daily macro- and micronutrient intake. ESI was characterized by a 2-fold 
greater hs-CRP value than LSI (p < 0.01). The two groups were comparable in terms of body 
composition, but LSI displayed higher physical performance (p < 0.05), daily PA (step count/day 
and time at moderate-to-vigorous PA (MVPA) were greater by 30% and 42%, respectively, p < 0.05), 
and daily intake of the antioxidant vitamins A (6590.7 vs. 4701.8 IU/day, p < 0.05), C (120.0 vs. 77.3 
mg/day, p < 0.05), and E (10.0 vs. 7.5 mg/day, p < 0.05) compared to ESI. Moreover, daily intake of 
vitamin A was inversely correlated with levels of hs-CRP (r = −0.39, p = 0.035). These results provide 
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evidence that elderly men characterized by low levels of systemic inflammation are more 
physically active, spend more time in MVPA, and receive higher amounts of antioxidant vitamins 
compared to those with increased systemic inflammation. 
Keywords: aging; chronic low-grade systemic inflammation; physical activity; nutrition; physical 
performance; chronic diseases 
 
1. Introduction 
Chronic exposure to antigens as well as to chemical, physical, and nutritional stressors that the 
immune system has to cope with, in combination with the dramatic increase in life expectancy, 
result in the overstimulation of the immune system with advancing age and the development of a 
chronic and persistent pro-inflammatory state [1,2]. This age-associated, low-grade, chronic 
inflammatory status has been termed as “inflammaging” [1] and is clinically assessed by measuring 
systemic concentrations of cytokines and acute-phase proteins, including interleukin-6 (IL-6), tumor 
necrosis factor-α (TNF-α), and C-reactive protein (CRP) [3]. Inflammaging represents a significant 
risk factor for age-related frailty, morbidity, and mortality [4,5] as many chronic diseases and 
geriatric syndromes such as cardiovascular diseases, atherosclerosis, metabolic syndrome, type 2 
diabetes mellitus, neurodegenerative diseases, cancer, and chronic obstructive pulmonary disease 
have been associated with chronic inflammation [6–9]. Moreover, increased levels of IL-6, TNF-α, 
and CRP in the elderly have been associated with lower muscle mass and physical performance 
[10–12] as well as with increased risk for sarcopenia and osteoporosis [13–15]. Thus, the concept of 
inflammaging appears to be a key determinant of successful aging and longevity and as such a 
valuable tool to counteract age-related pathologies [2]. 
To date, inflammaging is defined as a complex and multifactorial process whose origin cannot 
be simply attributed to a specific number of factors/mechanisms, as a complete understanding of the 
extent to which different tissues, organs, and biological systems contribute to its pathophysiology is 
lacking [3,16]. However, both physical activity (PA) and nutrition are considered powerful lifestyle 
factors that may, cooperatively or independently, influence both healthy aging and lifespan in 
humans [17,18]. Specifically, being physically active substantially reduces the risk of developing 
cardiovascular [17,18] and metabolic diseases [17,19], obesity [17,20], frailty [17,21,22], sarcopenia 
[23], osteoporosis [18,24], cognitive impairment [25], and mental health disorders [18,26] in a 
dose-response manner [27,28]. Numerous studies reported that higher volume of habitual PA is 
related to lower levels of IL-6, CRP, and TNF-α in older adults [29–41]. Most of these studies, 
though, are based on self-reported PA estimations [29–34,37,38,41] that may result in increased risk 
of recall bias [42] and therefore do not provide an objective determination of different intensity 
levels (i.e., light, moderate, vigorous, or very vigorous PA). However, to our knowledge, four 
studies have utilized accelerometry to provide an objective assessment of PA [35,36,39,40]. In two of 
them, an inverse relationship between PA and disease-related (chronic obstructive pulmonary 
disease and obesity) systemic inflammation was revealed in middle-aged adults [35,36]. Similarly, 
two other studies reported that time spent in MVPA is negatively associated with markers of 
systemic inflammation in the healthy elderly [39,40]. Although these data clearly suggest that 
habitual PA is inversely associated with mediators of systemic inflammation in older adults, a direct 
comparison of objectively assessed PA, sedentary time, and PA-related energy expenditure among 
the elderly with low and increased systemic inflammation is still lacking. 
Ideally, this comparison would be more conclusive by the concurrent examination of habitual 
PA/inactivity and dietary intake levels, since both factors may impact systemic inflammation. In fact, 
available data suggest that the role of nutrition and dietary pattern is pivotal for immune function 
and low-grade systemic inflammation [43–45]. Both macronutrient and micronutrient intake may 
interfere with immune responses, triggering either a pro-inflammatory or an anti-inflammatory 
effect [46]. Excessive consumption of glucose and saturated fatty acids (SFA) (particularly long-chain 
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SFA) are reported to activate pro-inflammatory markers in insulin-sensitive tissues [46,47] and may 
result in systemic inflammation [16], while high phospholipid consumption, especially that of 
polyunsaturated fatty acids (PUFA) and monounsaturated fatty acids (MUFA), elicit 
antiinflammatory properties and reduce the risk of chronic inflammation and its associated chronic 
diseases [48]. On the other hand, consumption of either plant- or dairy-based protein or amino acids 
may offer antiinflammatory effects by reducing levels of inflammatory mediators [46,49]. 
Furthermore, adequate intake of antioxidants and trace elements, particularly vitamins A, C, E, and 
selenium, also enhances immunity and elicits a protective effect against chronic inflammatory 
conditions [45]. However, to our knowledge, the literature lacks evidence regarding differences in 
dietary habits among older healthy adults with low and high systemic inflammation.  
Given the pivotal role of both PA and macronutrient/micronutrient intake in mediating 
immunity and chronic inflammatory responses, a direct comparison of them among older adults 
exhibiting low and elevated systemic inflammation may identify which parameters of these lifestyle 
factors function as discriminants of healthy aging and inflammaging. Therefore, the aim of the 
present study was to compare levels of objectively assessed habitual PA and dietary 
macronutrient/micronutrient intake, among otherwise healthy elderly men of low and increased 
systemic inflammation. 
2. Materials and Methods 
2.1. Experimental Design and Participants 
A total of fifty community-dwelling elderly men aged 65–75 years were recruited from the 
surrounding area of Thessaly (Greece) through postings, newspaper, and media advertisements. All 
volunteers completed a health history questionnaire and were also examined by a physician. In 
order to be included in the study, volunteers had to initially meet all of the following 
inclusion/exclusion criteria: (a) nonsmokers; (b) independently living; (c) absence of chronic disease 
(i.e., cancer, metabolic, cardiovascular, neurological, pulmonary, or kidney disease); (d) absence of 
inflammatory disease (i.e., osteoarthritis, rheumatoid arthritis); (e) absence of type 2 diabetes, and (f) 
no recent or current use of antibiotics or other medication that could affect inflammatory status (i.e., 
corticosteroids). Subsequently, those who fulfilled these criteria underwent assessment of body 
height, body weight, body composition, handgrip strength, and physical performance (via the SPPB) 
testing to estimate their weight status and stage of sarcopenia according to the European Working 
Group on Sarcopenia in Older People (EWGSOP) [50]. Volunteers who were characterized as 
presarcopenic/sarcopenic were excluded from the study at this stage, since substantial loss of 
skeletal muscle mass is accompanied by significant performance decline [50], resulting in lower 
levels of habitual PA [51]. Volunteers who were classified as obese were also excluded since obesity 
is linked to metaflammation, an adipose-tissue-mediated chronic inflammatory state that differs in 
terms of pathophysiology from inflammaging [6,16]. Accordingly, thirty-four volunteers who 
fulfilled the eligibility criteria participated in the study. The determination of inflammatory status 
was based on two consecutive measurements of high-sensitivity CRP (hs-CRP) and participants 
were grouped as “low systemic inflammation” (LSI: hs-CRP <1 mg/L) or “elevated systemic 
inflammation” (ESI: hs-CRP >1 mg/L) according to a previous report [52]. Participants were then 
provided with accelerometers and food diaries to monitor their habitual PA and daily 
macronutrient/micronutrient intake, respectively, over a 7-day period. They were fully informed 
about the aim and the experimental procedures of the study, as well as about the benefits involved, 
before obtaining written consent. The Institutional Review Board of the University of Thessaly 
approved the study and all procedures were in accordance with the 1975 Declaration of Helsinki (as 
revised in 2000).  
2.2. Body Composition 
Standing body mass and height were measured on a beam balance with stadiometer (Beam 
Balance-Stadiometer, SECA, Vogel & Halke, Hamburg, Germany) with participants wearing light 
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clothing and no shoes as described previously [53]. Body composition [including fat mass, fat-free 
mass (FFM), percent of fat, lean body mass (LBM)] was assessed by dual emission X-ray 
absorptiometry (DXA, GE Healthcare, Lunar DPX NT, Diegem, Belgium) with participants in supine 
position as described before [54]. Appendicular lean mass (ALM) and skeletal muscle mass index 
(SMI) were calculated as the sum of muscle mass (kg) of the four limbs (based on DXA scan) and as 
ALM divided by height by meters squared (kg/m2), respectively [50], while sarcopenia status was 
determined according to the criteria established by EWGSOP [50].  
2.3. Physical Activity 
Physical activity was monitored by using the accelerometers ActiGraph, GT3X+ (ActiGraph, 
Pensacola, FL, USA) over a 7-day period. Accelerometers were attached to elastic, adjustable belts 
and did not provide any feedback to the participants. Participants were taught how to wear the belt 
around the waist with the monitor placed on the right hip and they were asked to wear it throughout 
the day, except for bathing or swimming and sleep, for seven consecutive days. To be included in the 
analysis, participants had to have ≥four days with ≥10 wear hours/day (i.e., four valid days) [55]. 
Nonwear time was calculated using the algorithms developed by Choi et al. [56] for vector 
magnitude (VM) data and defined as periods of 90 consecutive minutes of zero counts per minute 
(cpm), including intervals with nonzero cpm that lasted up to 2 min and were followed by 30 
consecutive minutes of zero cpm. Daily activity and sedentary time were estimated according to VM 
data and expressed as steps/day and time in sedentary (<199 cpm), light (200–2689 cpm), moderate 
(2690–6166 cpm), vigorous (6167–9642 cpm), and moderate-to-vigorous (≥2690 cpm) PA [57]. The 
manufacturer software ActiLife 6 was utilized to initialize accelerometers and download data using 
60-s epoch length.  
2.4. Dietary Assessment 
Participants were taught by a registered dietitian how to estimate food servings and sizes of 
different food sources and how to complete food diaries. They were allowed to weigh out food 
servings, so that they could precisely report the amount of specific food portions, while they were 
also provided with colored photographs depicting different portion sizes that they could use to 
compare their food weights. Furthermore, complete instructions on how to describe portion sizes 
based on household measures or other standard units were also administered to our participants. 
Participants recorded their daily dietary intake for seven consecutive days, describing, in as much 
detail as possible all portions of food and drinks/water. For commercially available products, the 
name of the manufacturer, fat content (i.e., 1%. 2% etc), and other related information had to be 
noted. The Science Fit Diet 200 A (Science Technologies, Athens, Greece) dietary software was 
utilized to analyze diet recalls and data regarding total energy (kJ), protein (g/kg/day & g/day), 
leucine (g/day), branched chain amino acids (BCAA, g/day), carbohydrates (g/day), fat (g/day), 
vitamin A (IU/day), vitamin C (mg/day), vitamin E (mg/day), selenium (μg/day), polyunsaturated 
fatty acids (PUFA), and monounsaturated fatty acids (MUFA).  
2.5. Systemic Inflammation 
Blood samples were collected early in the morning between 07:00 and 09:00 am, after an 
overnight fasting. Participants were asked to avoid alcohol and abstain from intense physical 
activity for ≥48 h before blood sampling. Blood was drawn from an antecubital arm vein via a 
10-gauge disposable needle equipped with a Vacutainer tube holder (Becton Dickinson) with 
participants seated. To separate serum, blood samples were allowed to clot at room temperature and 
then centrifuged (15,000 g, 15 min, 4 °C). The supernatant was dispensed in multiple aliquots (into 
Eppendorf tubes) and stored at −80 °C for later analysis of hs-CRP. Serum hs-CRP was quantitatively 
measured in duplicate using the C-Reactive Protein (Latex) High Sensitivity assay (CRP LX High 
Sensitive, Cobas®) on a Cobas Integra® 400 plus analyzer (Roche) with a detectable limit of 0.01 
mg/dL and an inter-assay coefficient of one standard deviation (1 SD). 
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2.6. Statistical Analyses 
All data are presented as means ± SD. The normality of data was examined using the 
Shapiro–Wilk test (N = 17/group). Because our data sets in most of our variables differed 
significantly from normal distribution, we rejected the hypothesis of normality and applied 
nonparametric tests. To test differences in body composition, daily PA-related parameters, and 
dietary macronutrient/micronutrient intake among the two groups (LSI vs. HSI) a Kruskal–Wallis 
test was applied. Pearson’s correlation analysis was used to examine the relation of dietary 
antioxidant vitamins intake, number of steps, and time in MVPA per day with serum levels of 
hs-CRP. Correlation coefficients of r < 0.2, 0.2 < r < 0.7 and r > 0.7 were defined as small, moderate, 
and high, respectively. Effect sizes (ES) and confidence intervals (CI) were also calculated for all 
dependent variables using the Hedge’s g method corrected for bias. ES was interpreted as none, 
small, medium-sized, and large for values 0.00–0.19, 0.20–0.49, 0.50–0.79, and ≥0.8, respectively. The 
level of statistical significance was set at p < 0.05. Statistical analyses were performed using the SPSS 
20.0 software (IBM SPSS Statistics). The G * Power program (G * Power 3.0.10) was utilized to 
perform power analysis. With our sample size of 17/group we obtained a statistical power greater 
than 0.80 at an α error of 0.05. 
3. Results 
Participants’ characteristics are presented in Table 1. Participants were healthy and had no 
pathological levels of hs-CRP. The two groups, though, differed significantly in respect to hs-CRP 
values (ESI: 2.1 ± 0.8 vs. LSI: 0.7 ± 0.2 mg/dL, p = 0.00), with ESI displaying a 2-fold elevation in serum 
hs-CRP compared to LSI. Averaged BMI values in LSI and ESI were 27.3 ± 3.1 kg/m2 and 27.9 ± 2.5 
kg/m2, respectively, which classifies them as nonobese according to the criteria established by the 
World Health Organization (WHO) [58]. Moreover, all participants were characterized as 
nonsarcopenic, since they exhibited SMI >7.26 kg/m2, handgrip strength >30 kg, and physical 
performance score in SPPB >8. No differences were detected in respect to BMI, fat mass, percent of 
fat, FFM, LBM, ALM, SMI, and handgrip strength among groups. However, significant differences 
were observed in physical performance, with LSI achieving a higher SPPB score compared to ESI 
(LSI: 11.9 ± 0.2 vs. ESI: 11.2 ± 1.0; χ2 = 6.436, p = 0.016; ES = 0.90; 95% CI = −1.63, −0.17). 
Table 1. Participants’ characteristics. 
Parameter LSI (n = 17) ESI (n = 17) 
Age (years) 68.2 ± 2.6 68.7 ± 3.0 
Body Height (m) 1.71 ± 0.07 1.73 ± 0.04 
Body Weight (kg) 82.3 ± 8.5 85.2 ± 7.5 
BMI (kg/m2) 27.3 ± 3.1 27.9 ± 2.5 
Fat Mass (kg) 24.1 ± 7.0 26.3 ± 4.1 
Fat (%) 29.5 ± 6.6 31.8 ± 2.1 
Fat-Free Mass (kg) 56.3 ± 4.6 58.4 ± 5.2 
Lean Body Mass (kg) 53.3 ± 4.5 55.3 ± 5.1 
ALM (kg) 23.2 ± 2.4 24.4 ± 2.1 
SMI (kg/m2) 8.12 ± 0.7 8.13 ± 0.6 
Grip Strength (kg) 34.3 ± 5.5 36.7 ± 6.6 
SPPB (score) 11.9 ± 0.2 11.2 ± 1.0 1 
Sarcopenia Status Non-Sarcopenic Non-Sarcopenic 
hs-CRP (mg/L) 0.7 ± 0.2 2.1 ± 0.8 2 
Data are presented as mean ± SD. ALM: Appendicular Lean Mass; SMI: Skeletal Muscle Mass Index; 
SPPB: Short Physical Performance Battery; hs-CRP: High-Sensitivity CRP. 1 significant difference 
between groups, p < 0.05, 2 significant difference between groups, p < 0.01. 
Results comparing sedentary time and PA among groups are shown in Figure 1. The two 
groups were comparable in sedentary time throughout the day (LSI: 378.2 ± 98.7 vs. ESI: 370.5 ± 95.9 
min/day; χ2 = 0.008, p = 0.927) and in the time they spent in light PA/day (LSI: 342.9 ± 93.1 vs. ESI: 
331.7 ± 98.2 min/day; χ2 = 0.357, p = 0.550), while a trend for significantly more time spent in 
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moderate PA/day by the LSI group was also observed (LSI: 59.5 ± 16.7 vs. ESI: 44.1 ± 18.2 min/day; χ2 
= 3.637, p = 0.057). Interpretation of the level of moderate PA by group means examined in relation to 
the PA guidelines adopted by the WHO revealed that both groups met the recommendation for at 
least 150 min of moderate-intensity PA throughout the week. 
 
Figure 1. (A) Sedentary time, (B) time spent in light, (C) moderate, (D) vigorous, (E) 
moderate-to-vigorous (MVPA) PA, and (F) total step count throughout the day, in low (LSI) and 
elevated (ESI) systemic inflammation groups. Values are presented as mean ± SD. * denotes 
significant difference between groups at p < 0.05. 
By performing an individual examination in both groups, we found that all participants in LSI 
and approximately 86% of participants in ESI met this criterion. Significant differences between LSI 
and ESI were observed in MVPA and daily step count, with LSI spending more time in MVPA 
throughout the day (LSI: 65.2 ± 21.5 vs. ESI: 45.9 ± 19.8 min/day; χ2 = 3.997, p = 0.044; ES = 0.91; 95% CI 
= −1.68, −0.13) and performing more steps (LSI: 9000.1 ± 2496 vs. ESI: 6968.3 ± 2075 steps/day; χ2 = 
4.087, p = 0.043; ES = 0.86; 95% CI = −1.63, −0.08) than ESI, by 42% and 30%, respectively. The average 
step count/day for LSI was 9000.1 steps, which is close to the upper recommended limit for older 
adults (7100–10,000 steps/day) [59] while the ESI did not meet these recommendations, performing 
6968.3 steps/day. Almost 86% of participants in the LSI group performed >7100 steps daily while 
slightly more than half (53%) of participants in the ESI group did so. A longitudinal analysis 
combining both groups revealed a trend for an inverse correlation between hs-CRP level and daily 
step count (r = −0.37, p = 0.055). Time in vigorous PA/day did not differ among groups (LSI: 5.3 ± 6.9 
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vs. ESI: 1.0 ± 2.6 min/day; χ2 = 2.315, p = 0.128), probably because of a high interindividual variability. 
Moreover, the two groups demonstrated similar PA-related energy expenditure throughout the day, 
as no differences observed in terms of kJ/day (LSI: 2554.3 ± 1033.5 vs. ESI: 2654.3 ± 1041.8 kJ/day, p = 
0.798) and METs/day (LSI: 1.28 ± 0.1 vs. ESI: 1.23 ± 0.1 METs/day, p = 0.203) (Figure 2). 
 
Figure 2. Daily PA-related energy expenditure expressed as (A) kJ and (B) METs in low (LSI) and 
elevated (ESI) systemic inflammation groups. Values are presented as mean ± SD. * denotes 
significant difference between groups at p < 0.05. 
LSI and ESI demonstrated similar total energy and macronutrient intake throughout the day 
(Table 2). The two groups had a daily energy intake of 6949.6–6794.8 kJ, constituted by 15–16% 
protein, 38% carbohydrate, and 42% fat. The mean protein intake in both groups was 0.8 g/kg body 
weight/day, which represents the recommended daily allowance (RDA) that meets 97.5% of the 
population [60]. However, approximately 46% of participants in both groups had a daily protein 
intake of 0.5–0.7 g/kg body weight/day. Separate analysis in leucine and BCAA intake revealed that 
both LSI and ESI received 0.6 g of leucine/kg body weight/day and 0.13–0.14 g of BCAAs/kg body 
weight/day, which meets the current recommendations for amino acid intake in adults [60]. The two 
groups, though, differed significantly in respect to daily antioxidant vitamin intake, with the LSI 
group receiving higher amounts of vitamin A (LSI: 6590.7 ± 2219 vs. ESI: 4701.8 ± 1552.6 IU/day; χ2 = 
5.616, p = 0.018; ES = 0.95; 95% CI = 1.72, 0.18), vitamin C (LSI: 120.0 ± 55.5 vs. ESI: 77.3 ± 39.1 mg/day; 
χ2 = 5.421, p = 0.020; ES = 0.87; 95% CI = 1.63, 0.11), and vitamin E (LSI: 10.0 ± 2.9 vs. ESI: 7.5 ± 3.0 
mg/day; χ2 = 4.496, p = 0.034; ES = 0.75; 95% CI = 1.50, 0.01) than ESI, by 37%, 59%, and 33%, 
respectively. Moreover, by performing a longitudinal analysis of both groups we observed that daily 
vitamin A intake was inversely correlated with levels of hs-CRP (r = −0.39, p = 0.035) (Figure 3). On 
the contrary, daily intake of selenium (LSI: 93.2 ± 29.8 vs. ESI: 96.1 ± 29.7 μg/day, p = 0.793), PUFA 
(LSI: 10.1 ± 2.4 vs. ESI: 8.9 ± 2.6 g/day, p = 0.215), and MUFA (LSI: 43.7 ± 10.8 vs. ESI: 37.9 ± 10.9 g/day, 
p = 0.168) was comparable in the two groups. 
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Table 2. Dietary macronutrient and micronutrient intake in LSI and ESI groups. 
Parameter LSI (n = 17) ESI (n = 17) p Value χ2 
Total Energy (kJ/day) 6952.9 ± 1241.8 6797.8 ± 1136.8 0.771 0.085 
Protein     
g/day 63.8 ± 20.3 66.9 ± 14.6 0.183 1.770 
g/kg BM/day 0.8 ± 0.3 0.8 ± 0.2 0.817 0.054 
% of total calories 15 ± 2.7 16 ± 3.0   
Leucine (g/day) 4.89 ± 1.7 5.13 ± 1.2 0.430 0.624 
BCAAs (g/day) 11.38 ± 3.6 11.53 ± 2.4 0.533 0.389 
Carbohydrates     
g/day 156.2 ± 37.6 154.9 ± 52.7  0.901 0.016 
% of total calories 37.7 ± 6.9 37.5 ± 8.4   
Fat     
g/day 79.3 ± 12.5 73.7 ± 17.0 0.318 0.996 
% of total calories 42.0 ± 4.0 41.7 ± 7.1   
PUFA (g/day) 10.1 ± 2.4 8.9 ± 2.6 0.275 1.191 
MUFA (g/day) 43.7 ± 10.8 37.9 ± 10.9 0.359 0.840 
Vitamin A (IU/day) 6590.7 ± 2219.6 4701.8 ± 1552.6 1 0.018 5.616 
Vitamin C (mg/day) 120.0 ± 55.5 77.3 ± 39.1 1 0.020 5.421 
Vitamin E (mg/day) 10.0 ± 2.9 7.5 ± 3.0 1 0.034 4.496 
Selenium (μg/day) 93.2 ± 29.8 96.1 ± 29.7 0.589 0.292 
Data are presented as mean ± SD. BM: Body mass; BCAA: Branched chain amino acids; PUFA: 
Polyunsaturated fatty acids; MUFA: Monounsaturated fatty acids. 1 Significant difference between 
groups. 
 
Figure 3. The relationship between serum hs-CRP level and daily dietary intake of Vitamin A. 
4. Discussion 
The present study is the first, to our knowledge, to compare the levels of habitual PA, sedentary 
time, and dietary intake between healthy elderly men with low and elevated low-grade systemic 
inflammation (inflammaging). Our findings suggest that older adults characterized by low levels of 
systemic inflammation perform more steps and spent more time in MVPA throughout the day and 
they receive higher amounts of dietary antioxidant vitamins (i.e., vitamins A, C, and E) on a daily 
basis compared to their counterparts with elevated systemic inflammation. 
Participants were categorized as having either “low” or “elevated” low-grade systemic 
inflammation according to their serum levels of hs-CRP. This acute-phase protein is considered a 
valid and informative marker of inflammaging [61] and has been previously used as a single marker 
to identify levels of systemic inflammation in older adults [52]. The term inflammaging, first 
introduced by Franceschi and his colleagues [1], refers to the development of a chronic, low-grade 
inflammation phenotype with advancing age. However, the presence of obesity, either in young or 
older individuals, results in elevated systemic inflammation, which has been defined as 
metaflammation (metabolic inflammation) and is primarily mediated by the adipose tissue [6]. 
Although the underpinning mechanisms of inflammaging and metaflammation may be different, 
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these two chronic inflammatory conditions may overlap [16]. Therefore, in an attempt to focus on 
inflammaging in this study, we included only nonobese elderly men (according to WHO criteria). 
Moreover, LSI and ESI groups were very homogeneous in terms of body composition, since they did 
not differ in body weight, fat mass, percent of fat, FFM, and LBM. All participants were also 
nonsarcopenic according to the criteria established by the EWGSOP [50], since the existence of 
sarcopenia could act as a covariate in our investigation, interfering with their ability to habitually 
perform PA [51].  
Previous cross-sectional studies have investigated the association between habitual PA and 
inflammatory biomarkers in middle-aged and older adults [29–32,34–41]. However, only two 
utilized accelerometry to quantify not only the quantity but also the quality (intensity) of habitual 
PA in the otherwise healthy elderly with physiological and elevated chronic, low-grade systemic 
inflammation [39,40]. This study attempted to extend the current literature by providing insights 
concerning the differences in PA and dietary intake profile among elderly men with low and 
elevated low-grade systemic inflammation. The use of accelerometry to objectively assess the 
quantity and intensity of habitual PA is a strength of our study, as most of the previously cited 
studies [29–32,34,37,38,41] are based on questionnaires, self-reports, or interviews. The use of 
accelerometers over a 7-day period to assess PA and sedentary time has been reported to be a valid 
and reproducible methodological approach in the elderly [62]. 
Although sedentary time and time spent in light- and moderate-intensity activities throughout 
the day were similar between LSI and ESI, we noted that overall the LSI group performed more steps 
and spent more time in MVPA on a daily basis. This suggests that not only the volume of habitual 
PA but also the intensity in which daily physical activities are performed may interfere with the 
development of chronic, low-grade systemic inflammation in older individuals. Our findings further 
build on previous reports that higher volume of habitual PA is associated with lower levels of 
pro-inflammatory mediators in healthy elderly individuals [30,34,37] and COPD patients [35]. 
Moreover, this inverse association between PA and inflammation is suggested to be 
dose-dependent, so that the more physically active an individual is, the lower the chronic 
inflammatory milieu [30,32,41]. Although only a trend (r = −0.37, p = 0.055) for an inverse correlation 
between hs-CRP level and daily step number was observed in our study, possibly because of an 
interindividual variability in daily step counts of our participants (we used accelerometers whereas 
questionnaires were utilized by others), these findings collectively suggest that habitual PA may be 
associated with inflammaging in an inverse, dose-response pattern. Furthermore, it has been 
recently reported that the impact of PA on chronic low-grade inflammation is not only 
dose-dependent but also intensity-dependent, as moderate-to-vigorous activities induce greater 
improvements in the inflammatory profile of older adults while light- or moderate-intensity 
physical activities are accompanied by no changes in inflammatory mediators [63]. Indeed, 
Wahlin-Larsson et al. [40] found that in recreationally active elderly women, the time spent in 
MVPA is inversely associated with serum levels of CRP, a finding also reported in younger 
individuals [64]. The mechanism/s through which PA reduces or prevents low-grade systemic 
inflammation in the elderly remains to be elucidated. Observational, cross-sectional studies are not 
designed to identify the mechanisms that underline the effects of systematic PA on chronic 
inflammation and as such, more intervention studies are needed [42,63]. Based on the fact that 
inflammaging is tightly regulated by the balance between pro- and anti-inflammatory mediators 
[65], a possible mechanism could be that PA, and especially MVPA, suppresses the production of 
pro-inflammatory cytokines and molecules that trigger the inflammatory milieu, and enhances the 
production of anti-inflammatory mediators [42,63,66]. Moreover, the process of inflammaging may 
be further affected by the age-associated increase in the production of reactive oxygen and nitrogen 
species (RONS) that lead to redox balance disturbances and subsequent activation of the 
redox-sensitive NF-κB signaling pathway that stimulates the expression of numerous 
pro-inflammatory mediators such as TNF-α, IL-6, IL-1β, and CRP [49,67]. As such, a vicious cycle of 
RONS and pro-inflammatory molecule production is propagated, driving a chronic systemic 
pro-inflammatory phenotype [49,68]. Regular participation in moderate-to-vigorous intensity 
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exercise has been shown to attenuate both basal and exercise-induced levels of oxidative damage, 
enhance the antioxidant capacity, and improve the DNA repair machinery in healthy, elderly 
individuals [69,70]. Thus, it can be proposed that systematic MVPA may prevent the development of 
inflammaging by lowering the production of RONS and levels of oxidative damage in the elderly. 
LSI and ESI also differed significantly in terms of physical performance. More specifically, LSI 
exhibited higher performance in the SPPB test compared to ESI and this observation is in line with 
previous findings reporting that older adults with elevated systemic inflammation demonstrate 
lower physical performance [71,72]. Although the underlying mechanism leading from chronic 
inflammation to functional decline has not been clarified yet, it has been reported that systemic 
inflammation may impact physical performance by decreasing skeletal muscle mass [15,49]. 
However, in this study, the two groups demonstrated similar LBM, ALM, and SMI, indicating that 
the observed difference in physical performance was not muscle-mass-dependent. A previous 
report, though, by Wahlin-Larsson and colleagues [40] provided evidence that increased systemic 
inflammation influences muscle regeneration by decreasing the proliferation rate of myoblasts. In 
addition, increased inflammation and cytokine production may also reduce the quiescent satellite 
cells pool and attenuate their differentiation capacity [15]. Therefore, it can be assumed that elevated 
systemic inflammation may contribute to physical performance deterioration by attenuating the 
regeneration potential of the aged skeletal muscle. 
We also utilized 7-day recalls to perform a thorough screening of the dietary intake in the LSI 
and ESI groups, focusing on macronutrients and micronutrients that have been shown to elicit either 
a pro- or an anti-inflammatory effect, and could be therefore characterized as ‘key modifiers’ in the 
process of inflammaging. LSI and ESI demonstrated similar energy and macronutrient intake, 
consuming 6794.8–6949.6 kJ/day composed of 15–16% protein, 38% carbohydrates, and 42% fat. Our 
group recently conducted a literature review suggesting that protein intake, especially that of whey 
protein and soy or isoflavone-enriched soy protein, may indirectly offer antioxidative and 
anti-inflammatory benefits beyond its ability to stimulate skeletal muscle protein synthesis [49]. 
Also, Zhou et al. [73] performed a meta-analysis on the effects of whey protein supplementation on 
levels of CRP, concluding that increased whey protein intake may induce favorable effects on 
individuals with elevated baseline CRP levels. However, in this study, we noted that daily protein 
intake was similar between LSI and ESI, with both groups receiving on average ~0.8 g/kg BM/day, 
which is in line with WHO RDA for protein [60]. BCAA and leucine intake were also compared 
among groups to provide a qualitative determination of daily protein intake. Although leucine is 
classified as a BCAA, we decided to present it separately because its role may differ from that of the 
other BCAAs, especially in the elderly where a higher amount of leucine should be consumed 
through diet to efficiently stimulate muscle protein synthesis and preserve muscle loss [74,75]. In our 
present work, we observed that LSI and ESI had a similar daily intake of BCAAs and leucine, 
meeting the recommendations for amino acid intake in adults [60]. Daily carbohydrate intake was 
also similar among groups (154–156 g/day), indicating that it does not play a prominent role in the 
development of inflammaging. Previous reports have noted that only increased consumption of 
high glycemic index carbohydrates may be associated with increased levels of inflammation [76]. 
Unfortunately, the determination of glycemic index and glycemic load in our participants’ daily 
diets was not feasible. 
Similarly, no differences were observed in total fat consumption among groups, with LSI and 
ESI receiving 79 and 74 g/day, respectively, which corresponds in both groups to 42% of daily 
energy intake. Although previous reports have indicated that increased fat consumption is 
associated with elevated systemic markers of inflammation [76,77], this was not the case here. High 
fat diets, and primarily SFA, have been reported to induce substantial alterations in the gut 
microbial flora (i.e., increases gut mucosa permeability, epithelial brier disruption) that result in 
enhanced translocation of lipolysaccharide (LPS) in the circulation, thus promoting the development 
of low-grade systemic inflammation [77,78]. However, it should be highlighted here that not all SFA 
demonstrate equal properties and consumption of specific SFA (i.e., C14:0, C15:0, C17:0, CLA, and 
trans-palmitoleic) has been associated with positive effects on cardiovascular health [79]. On the 
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other hand, increased intake of MUFA and/or PUFA has been proposed to counteract the 
pro-inflammatory cascade by reducing the translocation of LPS in the circulation [77] and 
suppressing the eicosanoid and PAF inflammatory pathways [48]. Indeed, many studies have 
revealed an inverse association between higher intake of dietary PUFA and/or MUFA and levels of 
pro-inflammatory mediators such as hs-CRP and IL-6 [76]. In this study, although no statistically 
meaningful differences were observed in dietary MUFA and PUFA intake between groups, LSI 
displayed a higher intake of MUFA and PUFA, by 15% and 13.5%, respectively, compared to ESI. 
Interestingly, we noted significant differences between LSI and ESI in terms of antioxidant 
vitamin intake. More specifically, daily dietary intake of vitamins A, C, and E in LSI was higher by 
37%, 59%, and 33%, respectively, as compared to ESI. These vitamins play a major role in immune 
function, so that adequate intake enhances innate, cell-mediated, and humoral antibody immunity 
while deficiency promotes the opposite effects [45,80]. With aging, the production of reactive oxygen 
and nitrogen species and that of pro-inflammatory cytokines rises significantly, propagating a 
vicious cycle of oxidative stress and inflammation that promotes a chronic low-grade inflammatory 
state [49,68]. Vitamin A has been shown to promote a T-helper type 2 immune response by reducing 
the expression of pro-inflammatory cytokines (i.e., interferon-γ, TNF-α and IL-12) and 
adipocytokines (i.e., leptin) [45,80] while it may also inhibit the activation of the redox-sensitive 
nuclear factor-kappa B (NF-κB) [45,80], a principal mediator of the bidirectional interaction between 
oxidative stress and inflammation [49]. Moreover, the pivotal role of vitamin A in chronic 
inflammation is further supported by the fact that a deficit in vitamin A intake is associated with a 
pronounced pro-inflammatory state and inability to cope with pathogens, as well as with reduced 
phagocytic capacity of macrophages [45]. Vitamin C also reduces the production of 
pro-inflammatory cytokines through inhibition of the transcription factor NF-κB [45]. The 
anti-inflammatory effect of this micronutrient is further supported by a previous investigation 
where vitamin C intake was inversely associated with levels of CRP and tissue plasminogen 
activator (t-PA) antigen in elderly men [81]. Furthermore, vitamin C acts as a potent antioxidant, 
protecting cells from ROS-mediated oxidative damage, while it may also boost the synthesis of other 
antioxidants such as vitamin E [45]. Likewise, vitamin E is able to confer protection against oxidative 
stress by increasing the concentration of endogenous antioxidant enzymes, such as SOD, CAT, and 
GPX, and it also prevents oxidative damage in the cell membrane [45,82]. Evidence based on human 
studies indicates that vitamin E supplementation in older adults improves immune function [45] and 
is associated with a lower concentration of pro-inflammatory mediators [83]. Collectively, these data 
corroborate the higher antioxidant vitamin intake observed in LSI in the present study, indicating 
that vitamins A, C, and E may contribute to the control of low-grade systemic inflammation in the 
elderly. By contrast, no differences were observed in selenium intake between LSI and ESI, although 
selenium is also considered a micronutrient that may efficiently influence both innate and acquired 
immune function and may enhance the antioxidative defense system [45]. 
5. Conclusions 
We found that elderly men with low levels of systemic inflammation are characterized by 
higher quality and quantity of habitual PA and ingested higher amounts of antioxidant vitamins A, 
C, and E through normal diet when compared to those with increased systemic inflammation. To the 
best of our knowledge, this is the first study to directly compare elderly men of low and increased 
low-grade systemic inflammation in respect to habitual PA and dietary profile. PA and antioxidant 
vitamin intake appear to be discriminant factors of inflammaging and healthy aging. Future research 
should further explore the cause and effect as well as the dose-response relationship between PA 
and/or antioxidant vitamins and inflammaging. 
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